JKT · SRAJ.JK
PT Sejahteraraya Anugrahjaya Tbk
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
Loading market information…
JKT · HEAL.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:14 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Medikaloka Hermina Tbk’s quoted price sits in the lower half of its reported 52-week range, 66.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Medikaloka Hermina Tbk’s forward annual dividend is IDR 14 per share, paid annual. The forward yield is 2.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
PT Medikaloka Hermina Tbk’s next earnings report is currently expected on Apr 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Medikaloka Hermina Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, plastic and reconstructive surgery, neurosurgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, primary care family medicine, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, lactation counseling, and dermatology and venereology. It also provides services in the areas of ophthalmology, clinical microbiology, pediatric neurology, occupational, radiation oncology, orthopedics and traumatology, pulmonology, anatomical pathology, clinical pathology, anesthesiology, internal medicine, psychology, radiology, physical medicine and rehabilitation, neurology, sports medicine specialist, aviation specialist, radiation specialist, otorhinolaryngology, occupational therapy, and urology. In addition, the company offers digital subtraction angiography, gastroenterology, IVF clinic, sleep and snoring clinic, pain clinic, growth and development clinic, stem cell, palliative care, perinatology ward, integrated stroke, and medical tourism services. Further, it is involved in investment, service, trading, management consulting, nurse training, and education services. PT Medikaloka Hermina Tbk was founded in 1985 and is headquartered in Jakarta Timur, Indonesia.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| IDR 8 |
| IDR 1.69T+0.95% vs estimate |
| Q4 2024 | Mar 21, 2025 | IDR 5 | IDR 1.71T |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
IDR 1,880-IDR 20 (-1.05%)
PT Siloam International Hospitals Tbk’s quoted price sits in the lower half of its reported 52-week range, 34.72% below the high.
IDR 1,310-IDR 60 (-4.38%)
PT Mitra Keluarga Karyasehat Tbk’s quoted price sits in the lower half of its reported 52-week range, 51.66% below the high.
IDR 378+IDR 42 (+12.5%)
PT Metro Healthcare Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 60.83% below the high.
IDR 710IDR 0 (0.0%)
PT Famon Awal Bros Sedaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 25.65% below the high.
IDR 258+IDR 18 (+7.5%)
PT Sarana Meditama Metropolitan Tbk’s quoted price sits in the lower half of its reported 52-week range, 41.89% below the high.
IDR 845+IDR 45 (+5.63%)
PT Murni Sadar Tbk’s quoted price sits in the lower half of its reported 52-week range, 40.49% below the high.
IDR 195+IDR 2 (+1.04%)
PT Bundamedik Tbk’s quoted price sits in the lower half of its reported 52-week range, 20.73% below the high.
